Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,136.11
-2.1700-0.19%
Post-market: 1,138.882.77+0.24%19:58 EDT
Volume:1.89M
Turnover:2.15B
Market Cap:1.07T
PE:38.14
High:1,161.00
Open:1,156.63
Low:1,131.59
Close:1,138.28
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.91
T/O Rate:0.20%
Dividend:6.69
Dividend Rate:0.59%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:31.70
PE(LYR):49.50

Loading ...

Irish Central Bank Raises Growth Forecasts on AI Investment Boom

Reuters
·
4 hours ago

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
10 hours ago

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
10 hours ago

U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo

Reuters
·
10 hours ago

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Yesterday

Top Calls On Wall Street: Nvidia, Apple, AMD, Amazon, Palantir, Nokia, Eli Lilly and More

Tiger Newspress
·
Yesterday

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Yesterday

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Yesterday

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Yesterday

Lilly: Foundayo Has Captured Over 30% Of New Patient Share In The U.S. Oral Weight-Loss Drug Market

Bellwether Stocks Movement
·
Yesterday

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
Yesterday

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
Yesterday

GSK Doubles Down On Oncology: Buys Global Rights To Chimagen's Trispecific TCE For Up To $750 Million

Options & Short Sell
·
Yesterday

U.S. Research Roundup-Eli Lilly, McDonald's, Welltower

Reuters
·
Yesterday

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
Yesterday

Lilly's Foundayo Grabs 30% Of New U.S. Orforglipron Patients, Chipping Away At Novo's Head Start

Options & Short Sell
·
Yesterday

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Yesterday

Eli Lilly Stock (LLY) Has 45% Upside, Says Citigroup

TIPRANKS
·
Yesterday

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
Yesterday